维普中文期刊产品整合服务
106篇 您的检索式:作者名="Walker BD"
    题名 作者 年代 出处 被引量
1HIV-1Gag、Tat、Rev和Nef蛋白特异性的免疫应答显示文摘目的: 探讨中国HIV/AIDS患者HIV-1 Gag、 Tat、 Rev和Nef蛋白特异性CTL应答的特征.方法: 应用覆盖HIV-1B、 C亚型Gag、 Tat、 Rev和Nef蛋白的220个肽段作为抗原, 通过ELISPOT方法检测HIV/AIDS患者HIV特异性CTL应答.结果: 无论HIV-1B亚型还是HIV-1C亚型所构建肽库的应答强度和频率, 主要集中在Gag和Nef蛋白, Tat和Rev蛋白也有不同程度的应答.HIV-1 B、 C亚型间应答比较, 整体应答强度大致相同, 但免疫优势区间存在着一定的差异, B亚型Gagp24亚蛋白的288~313氨基酸区应答最强, 而C亚型Gagp24亚蛋白的155~181氨基酸区应答最强; 两个亚型免疫优势区应答频率最高的都是Nef蛋白106~143氨基酸区(48.1%). 结论: 中国人群CTL应答多集中在Gag和Nef蛋白, B、 C亚型间略有差异且存在交叉识别, 这对设计针对中国人群的HIV疫苗是有重要的意义.翟嵩 康文臻 于旭 王少扬 Walker BD Altfeld M 孙永涛 2005细胞与分子免疫学杂志2005,21,2:3
2Common variation in the LMNA gene (encoding lamin A/C) and type 2 diabetes - Association analyses in 9,518 subjects显示文摘Owen, KR Groves, CJ Hanson, RL Knowler, WC Shuldiner, AR Elbein, SC Mitchell, BD Froguel,P Ng, MCY Chan, JC Jia, WP Deloukas, P Hitman, GA Walker, M Frayling, TM Hattersley, AT Zeggini, E McCarthy, MI 2007中国生物学文摘2007,21,11:2
3Immune control of HIV; the obstacles of HLA and viral diversity显示文摘Walker BD Korber BT 2001Nat Immunol2001,2,6:1
4PD-1 and CTLA-4 inhibitory cosignaling pathways in I-IIV infection and the potential for therapeutic intervention 显示文摘Kaufmann DE Walker BD 2009J Immunol2009,182,10:1
5Hepatitis C virus infection显示文摘Lauer GM Walker BD 2001N Eng J Med2001,345,1:1
6Hepatitis C virus infection显示文摘Lauer GM Walker BD 2001N Engl J Med2001,345,1:1
7Hepatitis C virus infection显示文摘Lauer GM Walker BD 2001N Engl J Med2001,345,1:1
8Infection of CD127+ (interleukin-7 receptor + ) CD4+ ceils and overexpression of CTLA-4 are linked to loss of antigen- specific CD4 T cells during primary human immunodeficiency virus type 1 infection 显示文摘Zaunders JJ Ip S Munier ML Kaufmann DE Suzuki K Brereton C Sasson SC Seddiki N Koelsch K Landay A Grey P Finlayson R Kaldor J Rosenberg ES Walker BD Fazekas de St Groth B Cooper DA Kelleher AD 2006J Virol2006,80,10:1
9Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF 显示文摘Quigley M Pereyra F Nilsson B Porichis F Fonseca C Eichbaum Q Julg B Jcsneck JL Brosnahan K Imam S Russell K Toth I Piechocka-Trocha A Dolfi D Ange- losanto J Crawford A Shin H Kwon DS Zupkosky J Francisco L Freeman GJ Wherry Kaufmann DE Walker BD Ebert B Haining WN 2010Nat Med2010,16,10:1
10Hepatitis C virus infection显示文摘Lauer GM Walker BD N Engl J Med0,345,1:1
11Human immunod- eficiency virus type 1 evolution in vivo trached by DNA heterodu- plex mobility assays 显示文摘Delwart EL Sheppard HW Walker BD 1994J Viral1994,68,10:1
12Human Immunodefici ency virus type 1Evolution in vivo tracked by DNA heteroduplex mobility ass ays显示文摘Delwart EL Sheppard HW Walker BD 1994J Virol1994,68,10:1
13Hepatitis C virus infection 显示文摘Lauer GM Walker BD 2001The New England Journal of Medicine2001,345,1:1
14PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention 显示文摘Kaufmann DE Walker BD 2009J lmmunol2009,182,10:1
15Hepatitis C virus infection显示文摘LAUER GM WALKER BD 2001N Engl J Meal2001,345,1:1
16The great escape AIDS viruses and immune control显示文摘Goulder PJ Walker BD 1999Nature Med1999,5,11:1
17Hepatitis C virus infection 显示文摘Lauer GM Walker BD 2001N Engl J Med2001,345,1:1
18Hepatitis C virus infection显示文摘Lauer GM Walker BD 0,,1:1
19The cytotoxic T-lymphocyte response in HIV-1 infection显示文摘Kalams SA Walker BD 1994Clin Lab Med1994,14,2:1
20Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride : affinity for open and inactivated states 显示文摘Walker BD Singleton CB Bursill JA 1999Br J Pharmacol1999,128,2:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费